Constellation

Not a diagnostic tool, and not medical advice. Nothing here can tell you what you or anyone else is. If you’re seeking an assessment, that’s a conversation with a qualified clinician. What this can do is make the vocabulary legible, so that conversation starts further along.

Never change or stop a psychiatric medication because of something you read here. That’s a conversation with whoever prescribed it — stopping some of them abruptly is genuinely dangerous.

The reframe

Ask most people what “the spectrum” means and they’ll tell you it’s a group of people — the ones who are different. That’s a zoomed-in reading, and it’s backwards.

Think about the electromagnetic spectrum. Visible light is a narrow band that happens to be the part human eyes evolved to detect. Ultraviolet and infrared aren’t outside the spectrum; they’re on it, we just can’t see them. Nobody sensible defines the spectrum as “the bit we can see” and treats the rest as an anomaly.

Human brains work the same way. There is a continuous, many-dimensional range of attention, sensory processing, emotional regulation, pattern recognition, compulsivity, empathy, memory, and every other thing a brain does. What we call “neurotypical” is a densely populated region of that range — not the default it’s measured against.

The spectrum includes everyone. Diagnosis is what happens when someone lands far enough from the dense middle, on a dimension that matters enough, that the distance produces difficulty. It’s a threshold on a continuum, not a category you’re either in or out of.

And there’s only one substrate. Everything that happens in a mind is something happening in a brain — a physical organ shaped by genes, development, environment and experience at the same time, none of them optional. That’s why everything belongs on one map: not because the causes are the same, but because there was never a second place for any of it to live.

What’s on the map

Everything that describes a position on that range, and it doesn’t sort into a single list — the points are genuinely different kinds of object, and the map says which is which:

Conditions. Autism, ADHD, OCD, bipolar, schizophrenia, dyslexia, dyspraxia, eating disorders, PTSD. Formal diagnoses, with their histories and the arguments about where their edges are.

Dimensions. The underlying continua the diagnoses sit on — impulsivity, sensory sensitivity, compulsivity, emotional reactivity. Everyone has a value on each. This is the layer that makes the reframe concrete rather than rhetorical.

Mechanisms and experiences. Masking, time blindness, rejection sensitivity, shutdown, hyperfocus, alexithymia. Not diagnoses — things that happen, described by the people they happen to, and frequently more relevant to a life than the label above them.

Adjacent territory. Psychopathy, sociopathy, and other places where the conversation gets uncomfortable and usually stops. They’re on the range too. Leaving them off would be a choice about comfort rather than accuracy.

Nobody occupies one point. You sit somewhere on every dimension at once, weighted more heavily toward some than others — which is why the same person can carry traits that three different diagnoses would each claim as theirs.

Findings. The research that connects positions on the map to real-world outcomes — and this is where most published material goes wrong, so it’s where this one has to be strongest.

Why this matters more than it sounds

The cost of a categorical view isn’t philosophical. Someone arrives distressed, the distress gets treated, and nobody asks what’s been generating it since they were six. A study of adults being treated for major depression found full-syndrome ADHD in 12.5% of them — under-recognised, the paper says, because the cognitive symptoms of the two overlap. The same work describes ADHD as an independent risk factor for suicidal ideation.

So the thing being missed is not a footnote to the thing being treated. It’s frequently the thing carrying the risk.

Why the findings layer is the whole point

Claims like “a huge share of prisoners are neurodivergent” or “one in five CEOs is a psychopath” travel enormously well and are usually wrong or badly degraded in transmission. Two examples that are already in the build notes:

The prison-ADHD figure is widely quoted at around 25%. That came from a 2014 meta-analysis of 42 studies. A 2024 meta-analysis restricted to unselected samples put it at 8.3% — the earlier number was inflated by drawing on populations already selected for psychiatric contact. Still elevated. Not what the headline says.

The psychopathy claim traces to a study of 261 senior supply-chain management professionals — not chief executives. The finding was real; the headline was a substitution.

A map that repeats claims like these is worth nothing. A map that adjudicates them — states the claim, shows what the study actually measured, gives the better estimate where one exists, and marks its own confidence — is worth a great deal, because almost nobody is doing it.

The rules

• Show the disagreement. Where research conflicts, where clinicians and the people described disagree, where a term is falling out of use — that’s stated, not smoothed over.
• Label what kind of thing each point is. A formal diagnosis, a research construct, a clinically-adjacent idea, and a community term are four different epistemic objects. Presenting them at the same weight is the fastest way to lose a reader who knows the difference.
• No quiz, no checklist, no score. Those produce an answer, and an answer is exactly what this shouldn’t pretend to give.
• Corrections get published. Always.

Who it’s for

Anyone who has been handed a word and left to work out what it means. People trying to understand their own diagnosis, or someone else’s. And people who assume none of this applies to them — who are, per the entire premise, also on the map.